REVISTA ESPAÑOLA DE
CARDIOLOGÍA
ISSN: 1885-5857 Impact factor 2023 7.2
Corrected proofs Journal pre-proofs

Editorial comment
Is DOAC the preferred oral anticoagulation therapy after TAVI?

¿Son los anticoagulantes de acción directa la primera elección en pacientes sometidos a TAVI?

Gabriela Tirado-ConteabcdÁngel Sánchez-RecaldeabcdJosé Luis Zamoranoabcd
Late bleeding events in TAVI patients receiving vitamin K antagonists or direct oral anticoagulants
Alberto Alperi, Raul Ptaszynski, Isaac Pascual, Raquel del Valle, Daniel Hernández-Vaquero, Marcel Almendárez, Paula Antuna, Raul Ludeña, César Morís, Pablo Avanzas
https://doi.org/10.1016/j.rec.2024.06.001
View PDF
Lea este artículo en español
Share

Options

Identify yourself

Not yet a subscriber to the journal?

Revista Española de Cardiología (English Edition)
Subscribe to the journal

Purchase access to the article

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Phone for incidents

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960
Calls from outside Spain +34 932 415 960

E-mail

atencionalcliente@elsevier.com
Copyright © 2024. Sociedad Española de Cardiología
Are you a healthcare professional authorized to prescribe or dispense medications?